BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27530352)

  • 21. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.
    Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J
    Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA SNHG6 increases JAK2 expression by targeting the miR-181 family to promote colorectal cancer cell proliferation.
    Lai F; Deng W; Fu C; Wu P; Cao M; Tan S
    J Gene Med; 2020 Dec; 22(12):e3262. PubMed ID: 32840014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
    Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma.
    Lan T; Ma W; Hong Z; Wu L; Chen X; Yuan Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):11. PubMed ID: 28073380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Chen K; Hou Y; Liao R; Li Y; Yang H; Gong J
    Oncogene; 2021 May; 40(18):3217-3230. PubMed ID: 33824472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
    Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
    Tang J; Zhuo H; Zhang X; Jiang R; Ji J; Deng L; Qian X; Zhang F; Sun B
    Cell Death Dis; 2014 Dec; 5(12):e1549. PubMed ID: 25476897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
    Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
    Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
    Lin YH; Wu MH; Yeh CT; Lin KH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
    Chang S; Chen B; Wang X; Wu K; Sun Y
    BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
    Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
    J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.